PEACE-1: Long-term survival benefit with the addition of abiraterone to SoC in patients with de novo mHSPC

Lung, Respiratory and Thoracic Cancer

Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis

Lancet Oncol

Di Federico A, Stumpo S, Mantuano F, De Giglio A, Lo Bianco F, Pecci F, Alessi JV, Wang X, Sperandi F, Melotti B, Gelsomino F, Skoulidis F, Garassino MC, Peters S, Awad MM, Ardizzoni A, Ricciuti B

doi: 10.1016/S1470-2045(25)00429-2

SPECIAL REPORT

Genitourinary Cancer

Sustained OS Benefit with Enzalutamide Plus ADT in mHSPC Including Patients with Cardiometabolic Comorbidities

ESMO 2026

Genitourinary Cancer

CAPItello-281: Updated analysis shows clinically meaningful OS benefit with capivasertib plus abiraterone in patients with PTEN-deficient mHSPC

Lung, Respiratory and Thoracic Cancer

Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial

Lancet Oncol

Hassing MJ, Billingy NE, van den Hurk CJG, van den Heuvel MM, Verberkt CA, Becker-Commissaris A, Walraven I, SYMPRO-Lung consortium

doi: 10.1016/S1470-2045(26)00305-0

Further Publications

Impact of COVID-19 and vaccination on long-term survival in patients with solid malignancies: A nationwide cohort study

Eur J Cancer

Dimitrov G, Argirova R, Valkov T

doi: 10.1016/j.ejca.2026.116708

Gastrointestinal Cancer

Long-term survival and cure fraction in patients with advanced hepatocellular carcinoma under immunotherapy in randomized controlled trials and real-world data

Clin Cancer Res

Campani C, Shim JH, Bouattour M, Touchefeu Y, Delhoume V, Rosmorduc O, Pascale A, An J, Lee HC, Regnault H, Thabut D, Amaddeo G, Ningarhari M, Ollivier-Hourmand I, Métivier C, Ronot M, Ntandaja-Wandji L, Ozenne V, Sidali S, Marra F, Hollande C, Ganne-Carrié N, Nahon P, Peron JM, Lequoy M, Sharma R, Liver Cancer Group P, Allaire M, Nault JC

doi: 10.1158/1078-0432.CCR-25-4943

Lung, Respiratory and Thoracic Cancer

Long-term exposure to wildfire-related PM_2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study

Lancet Oncol

Zhang M, Wisnivesky JP, Qiu M, Danesh Yazdi M, Yin K, Wright RJ, Schwartz JD, Ekenga CC, Wright RO, Wei Y

doi: 10.1016/S1470-2045(26)00295-0

Lung, Respiratory and Thoracic Cancer

Long-term survival with PD-1/PD-L1 inhibitors plus platinum-based chemotherapy versus chemotherapy alone in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma: updated follow-up analysis

Lung Cancer

Tang Y, Du W, Zhang X, Yang X, Zhou Y, Fu S, Zhang L, Hong S

doi: 10.1016/j.lungcan.2025.108855

APCCC 2026

Genitourinary Cancer

Related content

Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis

Sustained OS Benefit with Enzalutamide Plus ADT in mHSPC Including Patients with Cardiometabolic Comorbidities

CAPItello-281: Updated analysis shows clinically meaningful OS benefit with capivasertib plus abiraterone in patients with PTEN-deficient mHSPC

Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial

Impact of COVID-19 and vaccination on long-term survival in patients with solid malignancies: A nationwide cohort study

Long-term survival and cure fraction in patients with advanced hepatocellular carcinoma under immunotherapy in randomized controlled trials and real-world data

Long-term exposure to wildfire-related PM2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study

Long-term survival with PD-1/PD-L1 inhibitors plus platinum-based chemotherapy versus chemotherapy alone in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma: updated follow-up analysis

Triplet Therapy in mHSPC: Patient Selection and Treatment Intensification

Long-term exposure to wildfire-related PM_2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study